Dr. Reddys Laboratories Limited (nyse:RDY) is set to announce second quarter earning results on Wednesday 28th October 2020, before market open.
Previous Quarter Performance
Dr. Reddys Laboratories Limited disclosed income for the first quarter of $ 0.46 per share, from the revenue of $ 584.87 million. The consensus estimates are income of $ 0.52 per share. The bottom line results missed street analysts by $ 0.06 or 11.54 percent.
Conference Call
Dr. Reddys Laboratories Limited will be hosting a conference call at 8:00 AM eastern time on 28th October 2020, to discuss its 2Q21 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.drreddys.com
Dr. Reddys Laboratories Limited operates as an integrated pharmaceutical company worldwide. It operates through three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products.
